PHARMACOLOGICAL CONSIDERATION OF ANTICONVULSANTS

Authors


  • Supported in part by a Research Career Development Award (NB-K5-6429) and a Research Grant (1-R01-NB07193) from the National Institute of Neurological Diseases and Blindness, and by a grant-in-aid from Geigy Pharmaceuticals.

  • Present Address: Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Ancillary